| |
| |
|
| Insider
Information: |
Scheibler Lukas |
| Relationship: |
Chief Research Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
68,299 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,680,736 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
68,299 |
|
|
| Total
Value |
$2,680,736 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -5.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Research Officer |
2023-12-01 |
68,299 |
2018-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
22,580 |
63,707 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$104,881 |
D/D |
(2,015) |
61,692 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-01-27 |
4 |
D |
$52.77 |
$28,601 |
D/D |
(542) |
61,150 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-02-10 |
4 |
D |
$51.21 |
$34,720 |
D/D |
(678) |
60,472 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• – – |
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,886 |
70,358 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$41,828 |
D/D |
(715) |
69,643 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-09-06 |
4 |
S |
$43.01 |
$75,526 |
D/D |
(1,756) |
68,299 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-12-01 |
4 |
OE |
$13.85 |
$138,500 |
D/D |
10,000 |
78,299 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Research Officer |
• • – |
2023-12-01 |
4 |
AS |
$60.00 |
$600,000 |
D/D |
(10,000) |
68,299 |
0 |
% |
|
34 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
